What is the recommended dose of tetanus antitoxin (Tetanus Immune Globulin) for prophylactic use in wound management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tetanus Antitoxin Dose for Prophylaxis

The recommended prophylactic dose of Tetanus Immune Globulin (TIG) for wound management is 250 units intramuscularly, administered as a single injection for wounds of average severity. 1, 2, 3

Standard Prophylactic Dosing

  • Administer 250 units IM as the standard prophylactic dose for tetanus-prone wounds in adults and children ≥7 years of age. 1, 2, 3

  • For children <7 years old, the dose may be calculated by body weight (4.0 units/kg), but it is advisable to administer the entire 250-unit dose regardless of the child's size, since theoretically the same amount of toxin will be produced regardless of body size. 3

  • When TIG and tetanus toxoid are given concurrently, use separate syringes and inject at separate anatomic sites to prevent interference with the immune response. 1, 2, 3

Clinical Algorithm for TIG Administration

TIG is indicated ONLY for patients with tetanus-prone wounds who have:

  • Fewer than 3 documented doses of tetanus toxoid (incomplete primary series), OR 2, 3
  • Unknown or uncertain vaccination history 2, 3

TIG is NOT needed for patients with:

  • ≥3 documented doses of tetanus toxoid, regardless of time since last dose 2, 3
  • Clean, minor wounds, even with incomplete vaccination history 3

Special Populations Requiring TIG

  • Immunocompromised patients (HIV infection, severe immunodeficiency) should receive TIG for contaminated wounds regardless of their tetanus immunization history. 4

  • If TIG supplies are limited, prioritize persons aged >60 years and immigrants from regions other than North America or Europe, as they are less likely to have adequate protective antibody levels. 2, 4

Treatment Dose for Established Tetanus

  • For established tetanus cases (not prophylaxis), administer 250-500 units IM immediately to neutralize circulating tetanospasmin that has not yet bound to neural tissue. 5

  • The dosage should be adjusted according to the severity of the infection. 3

  • Note that TIG cannot reverse damage already caused by toxin that has bound to the central nervous system, highlighting the critical importance of prompt administration. 5

Critical Pitfalls to Avoid

  • Do not confuse the 10-year routine booster interval with the 5-year interval for contaminated wounds—this is the most common error in tetanus prophylaxis. 4

  • Never delay TIG administration while awaiting laboratory confirmation—tetanus is a clinical diagnosis requiring immediate intervention. 5

  • Do not assume adequate immunity based on age or history alone—38% of tetanus cases occur in patients ≥65 years, and only 21% of women >70 years have protective antibody levels. 5

  • Avoid using equine antitoxin if human TIG is available, as equine products carry higher risk of allergic reactions (including anaphylaxis and serum sickness) and provide shorter duration of protection. 5, 6

Product Characteristics

  • Human TIG provides longer-lasting protection than animal-derived antitoxin and causes significantly fewer adverse reactions. 1

  • The case fatality rate for tetanus remains 18-21% even with modern intensive care, underscoring the importance of proper prophylaxis. 2, 5

  • Complete primary tetanus vaccination provides long-lasting protection ≥10 years for most recipients, making TIG unnecessary in fully vaccinated individuals. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tetanus Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tetanus Vaccination for Nail Penetration Injury

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Established Tetanus Cases

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.